Search
  • Jill Forrest, President Oncology Strategies

More I-O targets mean more shots on goal.


New report provides update on the fast moving, ever growing field of study in immuno-oncology. Full report in September Cancer Reviews Nature Discovery, Yu et al.

Click on Charts to go to Article in Nature Reviews:

"The number of active drugs in development has grown from 2,030 to 3,876, a 91% increase from 2 years ago. Among the six different drug classes, cell therapy represents the largest growth" - September Cancer Reviews Nature Discovery, Yu et al.

Even more targets are in pursuit. Will the science lead to new innovative treatments?

Click on Charts to go to Article in Nature Reviews:


3 views

info@oncologystrategies.com   |   Overland Park, KS 66223

  • Facebook Basic Black
  • Twitter Basic Black
  • Black Instagram Icon